Prentiss Smith & Co’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-151	Closed	-$45.8K	–	65
2022 Q4	$45.8K	Buy	151 +11	+8%	+$1.62K	0.04%	61
2022 Q3	$8K	Hold	140	–	–	0.01%	62
2022 Q2	$8K	Hold	140	–	–	0.01%	68
2022 Q1	$16K	Hold	140	–	–	0.01%	73
2021 Q4	$20K	Hold	140	–	–	0.01%	79
2021 Q3	$31K	Hold	140	–	–	0.02%	75
2021 Q2	$32K	Hold	140	–	–	0.02%	76
2021 Q1	$42K	Hold	140	–	–	0.02%	74
2020 Q4	$53K	Buy	+140	New	+$49.1K	0.03%	76
2019 Q4	–	Sell	-170	Closed	-$73K	–	64
2019 Q3	$73K	Buy	+170	New	+$109K	0.05%	60
2019 Q1	–	Sell	-100	Closed	-$95K	–	61
2018 Q4	$95K	Buy	100 +30	+43%	+$36.1K	0.06%	62
2018 Q3	$101K	Hold	70	–	–	0.06%	85
2018 Q2	$113K	Hold	70	–	–	0.07%	81
2018 Q1	$114K	Hold	70	–	–	0.06%	87
2017 Q4	$118K	Sell	70 -30	-30%	-$39.7K	0.06%	90
2017 Q3	$140K	Hold	100	–	–	0.08%	73
2017 Q2	$112K	Buy	100 +30	+43%	+$24.8K	0.06%	85
2017 Q1	$38K	Hold	70	–	–	0.02%	130
2016 Q4	$43K	Hold	70	–	–	0.03%	126
2016 Q3	$50K	Sell	70 -30	-30%	-$23K	0.03%	120
2016 Q2	$73K	Hold	100	–	–	0.04%	105
2016 Q1	$60K	Hold	100	–	–	0.03%	113
2015 Q4	$57K	Hold	100	–	–	0.03%	119
2015 Q3	$56K	Hold	100	–	–	0.03%	112
2015 Q2	$80K	Hold	100	–	–	0.04%	105
2015 Q1	$83K	Hold	100	–	–	0.04%	102
2014 Q4	$72K	Buy	100 +50	+100%	+$39.1K	0.03%	117
2014 Q3	$35K	Buy	+50	New	+$40.4K	0.02%	124